Cem Akin

Definitions, Criteria and Global Classification of Mast Cell Disorders with Special Reference to Mast Cell Activation Syndromes: A Consensus Proposal

Peter Valent, Cem Akin, Michel Arock et al. · International Archives of Allergy and Immunology · 2011 · 641 citations · Full text

Life Sciences, Immunology, Pathology +12

Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FcεRI or FcγRI

Arnold S. Kirshenbaum, Cem Akin, Yalin Wu et al. · Leukemia Research · 2003 · 508 citations

Life Sciences, Cell Biology, Immunology +9

Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis

Jason Gotlib, Hanneke C. Kluin‐Nelemans, Tracy I. George et al. · New England Journal of Medicine · 2016 · 478 citations · Full text

Medicine, Hematology, Pharmacology +16

The c-KIT mutation causing human mastocytosis is resistant to STI571 and other KIT kinase inhibitors; kinases with enzymatic site mutations show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutations

Yongsheng Ma, Shan Zeng, Dean D. Metcalfe et al. · Blood · 2002 · 448 citations · Full text

Life Sciences, Genetics, Molecular Biology +16

Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness

Amy D. Klion, Pierre Noël, Cem Akin et al. · Blood · 2003 · 390 citations · Full text

Medicine, Internal Medicine, Pathology +15